Deborah S. Mortensen

1.2k total citations
28 papers, 785 citations indexed

About

Deborah S. Mortensen is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Deborah S. Mortensen has authored 28 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Organic Chemistry and 7 papers in Oncology. Recurrent topics in Deborah S. Mortensen's work include PI3K/AKT/mTOR signaling in cancer (11 papers), Estrogen and related hormone effects (5 papers) and Synthesis and biological activity (4 papers). Deborah S. Mortensen is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (11 papers), Estrogen and related hormone effects (5 papers) and Synthesis and biological activity (4 papers). Deborah S. Mortensen collaborates with scholars based in United States, Switzerland and Belgium. Deborah S. Mortensen's co-authors include Benita S. Katzenellenbogen, John A. Katzenellenbogen, Kathryn E. Carlson, Jun Sun, Alice L. Rodriguez, Shaun R. Stauffer, Zachary D. Aron, Brian E. Fink, Shuichan Xu and Lilly Wong and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Deborah S. Mortensen

25 papers receiving 768 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Deborah S. Mortensen United States	12	452	301	200	81	80	28	785
Guoshun Luo China	17	301 0.7×	423 1.4×	114 0.6×	32 0.4×	274 3.4×	46	858
Sébastien L. Degorce United Kingdom	13	232 0.5×	265 0.9×	52 0.3×	14 0.2×	100 1.3×	26	505
Ying‐Chao Duan China	13	479 1.1×	659 2.2×	31 0.2×	22 0.3×	108 1.4×	27	1.1k
Qinsheng Sun China	18	293 0.6×	576 1.9×	23 0.1×	73 0.9×	176 2.2×	35	807
Hank La United States	14	120 0.3×	428 1.4×	58 0.3×	11 0.1×	221 2.8×	23	792
Andreas Sellmer Germany	20	471 1.0×	711 2.4×	21 0.1×	68 0.8×	277 3.5×	35	1.1k
Anders Friberg Germany	13	168 0.4×	693 2.3×	29 0.1×	27 0.3×	135 1.7×	18	848
Jonathan L. Doty United States	8	172 0.4×	315 1.0×	14 0.1×	54 0.7×	78 1.0×	11	563
Carol Torcellini United States	10	231 0.5×	290 1.0×	26 0.1×	11 0.1×	103 1.3×	13	801
Mary Pat Beavers United States	17	192 0.4×	408 1.4×	25 0.1×	16 0.2×	63 0.8×	25	729

Countries citing papers authored by Deborah S. Mortensen

Since Specialization

Citations

This map shows the geographic impact of Deborah S. Mortensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah S. Mortensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah S. Mortensen more than expected).

Fields of papers citing papers by Deborah S. Mortensen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah S. Mortensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah S. Mortensen. The network helps show where Deborah S. Mortensen may publish in the future.

Co-authorship network of co-authors of Deborah S. Mortensen

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah S. Mortensen. A scholar is included among the top collaborators of Deborah S. Mortensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah S. Mortensen. Deborah S. Mortensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mortensen, Deborah S., et al.. (2025). Recent advances in glutarimide chemistry for cereblon-mediated targeted protein degradation: developments in synthesis and diversification. RSC Medicinal Chemistry. 17(1). 80–104. 1 indexed citations

Zhu, J., Jianqing Li, Deborah S. Mortensen, et al.. (2024). Development of a Buchwald–Hartwig Amination for an Accelerated Library Synthesis of Cereblon Binders. ACS Medicinal Chemistry Letters. 16(1). 89–95. 2 indexed citations

He, Chi, Hunter P. Shunatona, Jacob T. Edwards, et al.. (2024). Discovery of an Azabicyclo[2.1.1]hexane Piperazinium Salt and Its Application in Medicinal Chemistry via a Rearrangement. Organic Letters. 26(25). 5318–5322.

Norris, Stephen H., Dehua Huang, Gody Khambatta, et al.. (2023). Design and Synthesis of Novel Cereblon Binders for Use in Targeted Protein Degradation. Journal of Medicinal Chemistry. 66(23). 16388–16409. 30 indexed citations

Tasneen, Rokeya, Deborah S. Mortensen, Paul J. Converse, et al.. (2021). Dual mTORC1/mTORC2 Inhibition as a Host-Directed Therapeutic Target in Pathologically Distinct Mouse Models of Tuberculosis. Antimicrobial Agents and Chemotherapy. 65(7). e0025321–e0025321. 13 indexed citations

Goldberg, Ronald, Stacie Canan, Natalie A. Hawryluk, et al.. (2018). Discovery of a Stress-Activated Protein Kinase Inhibitor for Lymphatic Filariasis. ACS Medicinal Chemistry Letters. 9(3). 210–214. 4 indexed citations

Chen, Xi, Elena Díaz‐Rodríguez, Enrique M. Ocio, et al.. (2014). Genetic and Pharmacologic Evidence That mTOR Targeting Outweighs mTORC1 Inhibition as an Antimyeloma Strategy. Molecular Cancer Therapeutics. 13(2). 504–516. 8 indexed citations

Tsuji, Toshiya, et al.. (2014). 306 CC-115 inhibits DNA damage and repair pathways in vitro. European Journal of Cancer. 50. 100–100. 1 indexed citations

Mortensen, Deborah S., Kimberly E. Fultz, Matthew Hickman, et al.. (2014). 459 Preclinical characterization of CC-115, a novel inhibitor of DNA-PK and mTOR kinase currently under clinical investigation. European Journal of Cancer. 50. 150–150. 2 indexed citations

10.

Narla, Rama Krishna, Jason D. Katz, Julius Apuy, et al.. (2013). Abstract A165: Antitumor activity of mTOR kinase inhibitor CC-223 in a mouse model of prostate cancer.. Molecular Cancer Therapeutics. 12(11_Supplement). A165–A165. 1 indexed citations

11.

Mortensen, Deborah S., John Sapienza, Brandon Whitefield, et al.. (2013). Use of core modification in the discovery of CC214-2, an orally available, selective inhibitor of mTOR kinase. Bioorganic & Medicinal Chemistry Letters. 23(6). 1588–1591. 20 indexed citations

12.

Mortensen, Deborah S., Kimberly E. Fultz, Matthew Hickman, et al.. (2012). 337 The Discovery and Preclinical Characterization of CC-223, a Novel mTOR Kinase Inhibitor Under Clinical Investigation. European Journal of Cancer. 48. 103–103. 2 indexed citations

13.

Shih, Kent C., Johanna C. Bendell, Suzanne F. Jones, et al.. (2012). Phase I trial of an oral TORC1/TORC2 inhibitor (CC-223) in advanced solid and hematologic cancers.. Journal of Clinical Oncology. 30(15_suppl). 3006–3006. 14 indexed citations

14.

Xu, Shuichan, Toshiya Tsuji, Lisa M. Sapinoso, et al.. (2012). 338 CC-223, a Selective mTOR Kinase Inhibitor, Potently Inhibits Proliferation of a Large Panel of Cancer Cell Lines in Vitro. European Journal of Cancer. 48. 103–103. 1 indexed citations

15.

Mortensen, Deborah S., et al.. (2011). Discovery and SAR exploration of a novel series of imidazo[4,5-b]pyrazin-2-ones as potent and selective mTOR kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(22). 6793–6799. 24 indexed citations

16.

Mortensen, Deborah S., Rong Deng, Oskar Adolfsson, et al.. (2009). P3‐259: Characterization of the pharmacokinetics, pharmacodynamics, and distribution of anti‐abeta antibody MABT5102A. Alzheimer s & Dementia. 5(4S_Part_14). 1 indexed citations

17.

McKie, Jeffrey A., Shripad S. Bhagwat, Helen Brady, et al.. (2004). Lead identification of a potent benzopyranone selective estrogen receptor modulator. Bioorganic & Medicinal Chemistry Letters. 14(13). 3407–3410. 33 indexed citations

18.

Ghosh, Usha, Deshanie Ganessunker, Kathryn E. Carlson, et al.. (2003). Estrogenic diazenes: heterocyclic non-steroidal estrogens of unusual structure with selectivity for estrogen receptor subtypes. Bioorganic & Medicinal Chemistry. 11(4). 629–657. 55 indexed citations

19.

Mortensen, Deborah S., Alice L. Rodriguez, Jun Sun, Benita S. Katzenellenbogen, & John A. Katzenellenbogen. (2001). Furans with basic side chains: synthesis and biological evaluation of a novel series of antagonists with selectivity for the estrogen receptor alpha. Bioorganic & Medicinal Chemistry Letters. 11(18). 2521–2524. 36 indexed citations

20.

Fink, Brian E., et al.. (1999). Novel structural templates for estrogen-receptor ligands and prospects for combinatorial synthesis of estrogens. Chemistry & Biology. 6(4). 205–219. 195 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact